DGRA e.V.
The
Deutsche Gesellschaft für Regulatory Affairs e.V. (DGRA)
editThe Deutsche Gesellschaft für Regulatory Affairs e.V. (DGRA) is a scientific society that specializes in the field of drug approval. Founded in 1999, the DGRA serves as a platform for exchange between the pharmaceutical industry, universities, authorities and scientific institutions.
Main Mission and Values
editThe DGRA aims to promote education and training in the field of Drug Regulatory Affairs and to support the exchange of information between its members. It sees itself as a neutral mediator between industry, science and authorities in order to represent the interests of its members and to support the development of new regulations.
Key Products and Services
edit- Master's Program "Drug Regulatory Affairs": In cooperation with the Universität Bonn, the DGRA offers a part-time Master's program that focuses on the approval and regulation of drugs.
- Workshops and Conferences: Regular events to discuss current topics and developments in the field of drug approval.
- Networking: The DGRA provides its members with access to a broad network of experts from industry, universities and authorities.
Sustainability Goals and Initiatives
editThe DGRA focuses on the continuous improvement of education and information exchange in the field of Regulatory Affairs. By promoting educational programs and exchange between industry and science, the DGRA contributes to the sustainable development of the pharmaceutical industry. It supports adaptation to EU-wide laws and the globalization of markets, which is crucial for the approval of new drugs.
The DGRA is an important partner for all those who have to deal with the complex requirements of drug approval and offers a platform for dialogue between industry, science and authorities.